Production

In part 2 of our series on incretin mimetics, we cover the growth of GLP-1 analogues in obesity

In the third and final part of our series on incretin mimetics, we address pharma’s efforts to overcome supply and pricing issues

This three-part series will dig into incretin mimetics, their rise to fame in weight management and what it will take for the drug class to truly transform obesity care

Safely moving drug products requires new ways of thinking and working — with technology.

Advancements in patient-operated delivery systems offer safety and convenience

Through discussions that focused on innovative operational approaches as well as powerful patient-hosted sessions, the show sought to remind manufacturers to keep a patient-focused...

The pharma industry is running out of lab and manufacturing space — but there are options

The pre-show buzz: investors driving ESG, continuous manufacturing and reshoring

Critical biopharma applications require protection of media integrity

Recent developments in printing technology could transform the pharma industry

How modern chromatography data systems can help mitigate disruption

How reducing technology-addressable vaccine barriers affects coverage rates

What it will take to build resilient and sustainable supply chains for the future